Australasian COVID-19 Trial (ASCOT): A multi-centre randomised clinical trial to assess clinical, virological and immunological outcomes in patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care.

Abstract
The aim of this study is to test lopinavir/ritonavir and hydroxychloroquine to find out whether they are effective treatments for COVID-19 and to find out which treatment (or combination of treatments) is best.
Link
https://hdl.handle.net/10137/12743
Subject
COVID-19 (SARS-CoV-2)
Title
Australasian COVID-19 Trial (ASCOT): A multi-centre randomised clinical trial to assess clinical, virological and immunological outcomes in patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care.
Type of document
Interventional/Clinical trials research
Entity Type
Project

Files:

NameSizeformatDescriptionLink
https://digitallibrary.health.nt.gov.au/nthealthserver/api/core/items/65edfa35-0d58-4382-a6c9-99f5d595a7f1